“Promising” Trend: FDA Acts On Unapproved Drugs, Tainted Supplements
This article was originally published in The Tan Sheet
Executive Summary
U.S. Marshals' seizure of unapproved erectile dysfunction drugs from Shangai Distributors may be evidence of a promising trend of FDA following through on warning letters to companies marketing unapproved new drugs mislabeled as supplements, according to food and drug attorney Marc Ullman
You may also be interested in...
Hi-Tech Prosecution Offers FDA Model For Pursuing Bad Actors – Lawyer
The successful prosecution of Hi-Tech Pharmaceuticals for counterfeiting generic Rx drugs should encourage FDA to pursue criminal charges against other companies selling adulterated products, according to food and drug attorney Marc Ullman
Hi-Tech Prosecution Offers FDA Model For Pursuing Bad Actors – Lawyer
The successful prosecution of Hi-Tech Pharmaceuticals for counterfeiting generic Rx drugs should encourage FDA to pursue criminal charges against other companies selling adulterated products, according to food and drug attorney Marc Ullman
Hi-Tech Prosecution Offers FDA Model For Pursuing Bad Actors – Lawyer
The successful prosecution of Hi-Tech Pharmaceuticals for counterfeiting generic Rx drugs should encourage FDA to pursue criminal charges against other companies selling adulterated products, according to food and drug attorney Marc Ullman